Clinical Trials Directory

Trials / Unknown

UnknownNCT00438217

Analysis of Genetic and Environmental Parameters Influencing Growth Rate of Precocious Puberty Children

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
100 (planned)
Sponsor
University of Pisa · Academic / Other
Sex
All
Age
1 Year – 18 Years
Healthy volunteers
Accepted

Summary

The goal of CPP-EDG 01 study is to assess possible genetic and/or environmental parameters which may influence the growth rate of children affected by precocious puberty. In this view, we are collecting clinical data and biological samples of children attended as outpatients at the Pediatric Endocrine Center of Pisa from 1998 to present (the study is still open). From biological (blood) samples, gene polymorphisms such as endocrine disruptor levels are determined and compared to different growth pattern of pediatric patients treated with different GnRH agonists.

Conditions

Interventions

TypeNameDescription
DRUGTriptorelin (GnRH agonists)
DRUGLeuprolide (GnRH agonists)

Timeline

First posted
2007-02-22
Last updated
2007-02-22

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT00438217. Inclusion in this directory is not an endorsement.